Discontinuous to Continuous Therapy with 0.2 μg/day Fluocinolone Acetonide implant (FAc) Leads to Reduction in Treatment Frequency for Diabetic Macular Edema (DME)

被引：0
|
作者：
Adams, Olufemi E. [1 ]
Schechet, Sidney [1 ]
Hariprasad, Seenu [1 ]
机构：
[1] Univ Chicago, Ophthalmol, Chicago, IL 60637 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2614
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 μg intravitreal implant for diabetic macular edema
    Currie, Craig J.
    Holden, Sarah E.
    Owens, David R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 : 33 - 43
  • [32] ASSESSMENT OF COST-EFFECTIVENESS OF A 0.2 MCG/DAY FLUOCINOLONE ACETONIDE (FAC) IMPLANT IN PATIENTS WITH CHRONIC DIABETIC MACULAR OEDEMA (DMO) IN AN EYE WITH CATARACT
    Beiderbeck, A.
    Aballea, S.
    Pochopien, M.
    Bellier, L.
    Toumi, M.
    VALUE IN HEALTH, 2019, 22 : S574 - S574
  • [33] Health-economic evaluation of fluocinolone acetonide 190 μg implant in people with diabetic macular edema
    Holden, Sarah E.
    Currie, Craig J.
    Owens, David R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 : 45 - 52
  • [34] Efficacy and Safety of Fluocinolone acetonide (FAc) implant (ILUVIEN) for treating Diabetic Macular Edema (DME) - A 3-year US Retrospective, multi-center Audit
    Wang, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [35] REAL-LIFE EFFICACY WITH ILUVIEN® (FLUOCINOLONE ACETONIDE [FAC]) IN DIABETIC MACULAR EDEMA (DME) PATIENTS IN 4 PORTUGUESE OPTHALMOLOGY UNITS
    Meireles, Angelina
    Pessoa, Bernardete
    Coelho, Joao
    Teixeira, Carla
    Falcao, Manuel Alberto
    Goncalves, Rita
    Silva, Marta Ines
    Castro e Sousa, Joao Paulo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [36] Clinical Effectiveness of the 0.19-mg Fluocinolone Acetonide (FAc) Intravitreal Implant for Diabetic Macular Edema: Anatomic, Visual and Treatment Burden Outcomes
    Morozova, Christine
    Humayun, Lucas
    Tabandeh, Homayoun
    Boyer, David S.
    Dayani, Pouya N.
    Rahhal, Firas M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [37] Effect of fluocinolone acetonide 0.2 μg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study
    Grewal, Dilraj S.
    Fletcher, Donald C.
    Hariprasad, Seenu M.
    Suner, Ivan J.
    BMJ OPEN OPHTHALMOLOGY, 2019, 4 (01):
  • [38] Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes
    Alberto La Mantia
    Alan Hawrami
    Heidi Laviers
    Sudeshna Patra
    Hadi Zambarakji
    International Journal of Ophthalmology, 2018, (12) : 1951 - 1956
  • [39] Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    William Fusi-Rubiano
    Rebecca R. Blow
    Mark Lane
    Rupal Morjaria
    Alastair K. Denniston
    Ophthalmology and Therapy, 2020, 9 : 205 - 205
  • [40] Diabetic macular edema outcomes in eyes treated with fluocinolone acetonide 0.2 μg/d intravitreal implant: real-world UK experience
    El-Ghrably, Ibraheem
    Steel, David H. W.
    Habib, Maged
    Vaideanu-Collins, Daniela
    Manvikar, Sridhar
    Hillier, Roxane J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (03) : 357 - 362
12345